Conventional IPR protection usually implies granting exclusive or monopoly rights over an invention¹³. Such exclusive rights however may restrict access, and are thus not necessarily the preferred option from a public health perspective.

¹³ There are exceptions, e.g. in case of trade secret protection, exclusivity does not apply.